In a landmark development for oncology care in India, Fortis Memorial Research Institute, Gurugram has unveiled the country's first dedicated Centre for Advanced Myeloma and Lymphoma Care. This pioneering initiative marks a transformative moment in blood cancer treatment, offering patients from India and across the globe access to world-class, subspecialty-focused hematological oncology under one roof. For international patients exploring medical tourism in India for oncology, this centre represents a compelling new destination for hope, healing, and cutting-edge care.
Blood cancers — including multiple myeloma and various forms of lymphoma — affect millions of patients worldwide each year. Despite significant advances in treatment, access to highly specialized, protocol-driven care remains limited in many countries. Fortis Gurugram's new centre aims to bridge that gap, bringing together expert clinicians, advanced diagnostics, and the latest therapeutic technologies in a single, patient-centric facility.
Get a Free Consultation for Blood Cancer Treatment in India
What Makes This Centre a Game-Changer in Blood Cancer Treatment in India?
The launch of this centre is not merely an institutional milestone — it signals a new era in how myeloma and lymphoma are diagnosed and treated in India. Here is what sets it apart:
- India's First Dedicated Facility: Unlike general oncology departments, this centre focuses exclusively on myeloma and lymphoma, enabling deeper clinical expertise and more refined treatment pathways.
- Multidisciplinary Team (MDT) Approach: Patients benefit from coordinated care involving hematologists, medical oncologists, radiation oncologists, bone marrow transplant specialists, and supportive care experts.
- Access to Novel Therapies: The centre offers access to newer-generation treatments including CAR-T cell therapy, targeted therapies, monoclonal antibodies, and immunotherapy protocols that are transforming outcomes globally.
- State-of-the-Art Diagnostics: Advanced molecular diagnostics, next-generation sequencing (NGS), and flow cytometry enable precise disease staging and personalized treatment planning.
- Bone Marrow Transplant (BMT) Expertise: Fortis Gurugram is one of India's most experienced centres for autologous and allogeneic bone marrow transplants, a cornerstone of myeloma and high-risk lymphoma management.
Understanding Multiple Myeloma and Lymphoma: Why Specialized Care Matters
What Is Multiple Myeloma?
Multiple myeloma is a cancer of plasma cells — a type of white blood cell found in the bone marrow. It accounts for approximately 10% of all blood cancers and can cause bone pain, kidney damage, anemia, and increased susceptibility to infections. While once considered difficult to treat, modern therapies have significantly extended survival and quality of life for myeloma patients. Treatment typically involves proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and in eligible patients, autologous stem cell transplantation (ASCT).
What Is Lymphoma?
Lymphoma is a group of blood cancers that originate in the lymphatic system. It is broadly classified into Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), with NHL encompassing dozens of subtypes including diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, and T-cell lymphomas. Treatment strategies vary significantly by subtype and disease stage, making subspecialty expertise critical to achieving optimal outcomes.
Why Does Subspecialty Focus Matter?
General oncology departments manage a wide range of cancers, which can limit the depth of experience with rare or complex blood cancer subtypes. A dedicated myeloma and lymphoma centre allows physicians to build concentrated expertise, participate in clinical trials, adopt cutting-edge protocols faster, and deliver outcomes that are consistently benchmarked against international standards. For patients traveling from abroad, this translates to higher diagnostic accuracy, more personalized treatment plans, and better overall outcomes.
Advanced Treatment Modalities Available at the Centre
The Fortis Gurugram Centre for Advanced Myeloma and Lymphoma Care brings together a comprehensive portfolio of treatment options:
1. CAR-T Cell Therapy
Chimeric Antigen Receptor T-cell (CAR-T) therapy is one of the most exciting breakthroughs in cancer immunotherapy. It involves genetically engineering a patient's own T-cells to recognize and destroy cancer cells. CAR-T therapy has shown remarkable results in relapsed or refractory large B-cell lymphoma and multiple myeloma, offering hope to patients who have exhausted conventional treatment options.
2. Autologous and Allogeneic Bone Marrow Transplant
Fortis Gurugram is a nationally recognized centre of excellence for bone marrow and stem cell transplantation. The transplant program supports high-dose chemotherapy followed by stem cell rescue for eligible myeloma patients, as well as allogeneic transplants for high-risk or relapsed lymphoma cases.
3. Targeted Therapies and Immunotherapy
The centre administers the latest targeted agents including daratumumab, bortezomib, lenalidomide, ibrutinib, venetoclax, rituximab, and bispecific antibodies — therapies that have dramatically changed the treatment landscape for both myeloma and lymphoma over the past decade.
4. Precision Oncology and Molecular Profiling
Every patient undergoes comprehensive genomic and molecular profiling to identify mutations, chromosomal abnormalities, and biomarkers that guide therapy selection. This ensures that treatment is truly personalized — not just standardized.
5. Radiation Oncology Integration
For lymphoma patients requiring radiation, the centre integrates advanced radiation techniques including intensity-modulated radiation therapy (IMRT) and proton therapy (available within the Fortis network), minimizing toxicity to surrounding healthy tissue.
6. Supportive and Palliative Care
Managing side effects, maintaining quality of life, and providing psychological support are as important as the primary cancer treatment. The centre offers comprehensive supportive care services including nutritional counseling, pain management, and mental health support throughout the treatment journey.
Why Choose Fortis Gurugram for Myeloma and Lymphoma Treatment?
Fortis Memorial Research Institute, Gurugram is consistently ranked among India's top hospitals and is internationally accredited by the Joint Commission International (JCI) and NABH. Here is why it continues to attract patients from over 50 countries:
- World-Renowned Hematologists: The centre is led by nationally and internationally recognized specialists with decades of experience in blood cancer management.
- JCI-Accredited Quality Standards: International accreditation ensures that clinical protocols, patient safety measures, and infrastructure meet the highest global benchmarks.
- Cost-Effective Treatment: Treatment costs at Fortis Gurugram are 60–80% lower than comparable care in the US, UK, or Western Europe, without any compromise on quality or outcomes.
- Seamless International Patient Services: Dedicated international patient coordinators assist with medical visa facilitation, airport transfers, accommodation, language interpretation, and telemedicine consultations prior to arrival.
- Participation in Global Clinical Trials: The centre actively participates in international oncology trials, giving eligible patients access to investigational therapies not yet commercially available.
- Proximity to Delhi IGI Airport: Located just 30–40 minutes from Indira Gandhi International Airport, Gurugram is one of the most accessible medical destinations in Asia.
Explore India as a Medical Tourism Destination
Who Should Consider Traveling to Fortis Gurugram for Blood Cancer Care?
This centre is particularly well-suited for:
- Patients with newly diagnosed multiple myeloma seeking a comprehensive treatment plan from subspecialists
- Individuals with relapsed or refractory myeloma or lymphoma who have not responded to standard therapies abroad
- Patients seeking CAR-T cell therapy or bone marrow transplantation at significantly lower cost
- International patients from Africa, the Middle East, Southeast Asia, and Central Asia where subspecialty blood cancer expertise is limited
- Patients requiring second opinions on diagnosis, staging, or treatment strategy from world-class hematologists
- Those looking for access to clinical trials for novel myeloma or lymphoma agents
How Ginger Healthcare Can Help You Access This Centre
At Ginger Healthcare, we specialize in connecting international patients with India's finest hospitals and specialists. Our dedicated team can assist you with every step of your medical journey to Fortis Gurugram's new Centre for Advanced Myeloma and Lymphoma Care:
- ✅ Free medical opinion from top hematologists at Fortis Gurugram
- ✅ Transparent cost estimates with no hidden charges
- ✅ Medical visa assistance and travel logistics support
- ✅ Accommodation arrangements near the hospital
- ✅ Airport pickup and local transportation
- ✅ Language interpretation services in multiple languages
- ✅ Post-treatment follow-up coordination with your home country physician
We understand that a cancer diagnosis is one of life's most difficult moments. Our mission is to ensure that no patient is denied access to world-class care simply because of geography or cost. Let us be your trusted partner on this journey.
Explore Oncology & Blood Cancer Treatment Options
Conclusion: A New Chapter in Blood Cancer Care in India
The launch of India's first Centre for Advanced Myeloma and Lymphoma Care at Fortis Gurugram is a watershed moment — not just for Indian healthcare, but for the global oncology community. It reinforces India's position as a world-leading destination for specialized, affordable, and compassionate cancer care. Whether you are a patient seeking a second opinion, pursuing advanced therapies, or looking for a bone marrow transplant, Fortis Gurugram's new centre offers a credible, internationally accredited, and cost-effective alternative to treatment in high-income countries.
If you or a loved one is battling multiple myeloma or lymphoma, do not let distance or cost stand between you and the best possible care. Reach out to Ginger Healthcare today, and let us help you take the first step toward treatment at one of Asia's most advanced blood cancer facilities.
Request a Free Medical Opinion Plan Your Medical Trip to India
